
January 10, 2027 (InterContinental San Francisco) — We’re pleased to announce that Xun Gui, CEO of Nexuce Therapeutics, will present at The 8th ACCESS ASIA BD Forum @ JPM 2027.
Hosted by YAFO, ACCESS ASIA builds on the success of ACCESS CHINA, expanding the platform’s reach to foster cross-border connections between Asian biotech innovators and global pharmaceutical companies, investors, and strategic partners. Taking place on January 10, 2027, at the InterContinental San Francisco, the forum will provide a global platform for Asian biotech companies to showcase their innovations, connect with potential partners, and identify new business development and collaboration opportunities. View more information at: https://biotochina.org/
About the Speaker
Chief Executive Officer | Nexuce Therapeutics
- VP & Board Member of Mabwell Bioscience, leading early-stage R&D and innovative antibody discovery
- Brings expertise in next-genT-cell engager platform, key contributor of LILRB4 target, enabled Nexuce’s lead clinical program
- Global BD experience, originated assets for BD deals with Calico and Aditum
- PhD, Xiamen University; Postdoctoral training, UT Health
About The 8th ACCESS ASIA BD Forum @ JPM 2027
The 8th ACCESS ASIA BD Forum @ JPM 2027 is scheduled to be held on January 10, 2027, at the InterContinental San Francisco.
This full-day forum will feature keynote speeches, panel discussions, corporate presentations, company showcases, and 1-on-1 partnering meetings connecting Asia’s leading biotech innovators with global pharma, investors, and strategic partners.
Date: January 10, 2027 (Sunday)
Venue: InterContinental San Francisco
View more information at: https://biotochina.org/2026/10/28/access-asia-jpm2027/

MORE INFORMATION
Contact Us
To register as an attendee for The 8th ACCESS ASIA BD Forum @ JPM 2027, please visit:
https://jsj.top/f/AqkB9m?x_field_1=Speaker+Promotion
For more information, please contact:
Wendi Xiang